Clinical Trial Update: PSilocybin for psYCHological and Existential Distress in PALliative Care (PSYCHED-PAL) [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/Phase 2 clinical trial update evaluating psilocybin for depression, anxiety, distress, and emotional distress in palliative care, currently recruiting…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Anxiety Disorders
• Major Depressive Disorder

Drugs mentioned

• Psilocybin (psilocybin)

Snippet

Sponsor: Ottawa Hospital Research Institute | Conditions: Depression, Anxiety, Distress, Emotional | Phase 1, Phase 2 | Status: RECRUITING